Govt plan to Regulate the sale Of Fairness Creams Containing Steroids

After analyzing the side effects of the steroids on the skin, the health ministry planned to regulate the over-the-counter sale of fairness creams carrying corticosteroids. Corticosteroids is a steroid hormone is known to damage skin damage and other health hazards.

Willingness to get Fair skin, and obsession with fairness will going to face a regulatory crackdown as no one can purchase creams without prescriptions.  To improve the effectiveness of lightening skin, some fairness cream manufacturers add corticosteroids, but these are very dangerous to the skin.

According to skin specialists, it is impossible to filter how many companies use steroids as producers not mentioned on their packs, in breach of labeling rules. Dermatologists said these creams not come under schedule H drugs, simply means anyone can buy over the counter and used without any prescription.

According to the talks, A notification will be released soon and the government has proposed amendments to the Drugs and Cosmetic Rules, 1945 inserting potent corticosteroid ingredients in Schedule H, which would restrict the over-the-counter sale of these topical creams.

Dermatologists experienced there is a link between these creams and cases of Topical Steroid Damaged Face (TSDF)’ s type of skin damage due to the steroid used in creams. Due to wide-spread of steroids, it becomes hard to treat simple skin ailments. There is a huge increase in the number of patients who are experiencing the side-effects of steroid use.

And it is recommended by the drug technical body-Drugs Technical Advisory Board to insert steroid-laced fairness cream in schedule H.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

Six fake doctors arrested in Hyderabad

Six fake doctors arrested in Hyderabad